Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesWhich components of malnutrition–inflammation–atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy
Nephrology, 10/06/09
Jakuszewski P et al. – Atherosclerosis is more common in HD patients with diabetic nephropathy; and this fact may explain the poor outcome of these patients and indicates the challenge in diagnostic and therapeutic management.
Related Articles
Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity
Platelets, 10/30/09
Relevance Score: 91%
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)
Nephrology Dialysis Transplantation, 10/16/09
Relevance Score: 90%
Renal Cell Carcinoma in Association With IgA Nephropathy in the Elderly
The American Journal of the Medical Sciences, 11/13/09
Relevance Score: 89%
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetes
Diabetes Care, 10/28/09
Relevance Score: 89%
DNase1 activity in systemic lupus erythematosus patients with and without nephropathy
Rheumatology International, 10/26/09
Relevance Score: 89%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Subclinical Atherosclerosis In Young beta-thalassemia Major Patients
Hemoglobin, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Today in Inflammation...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging inflammatory markers for assessing coronary heart disease risk
Current Cardiology Reports, 12/11/09
Comparison of the long-term prognostic value of Cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome
Atherosclerosis, 12/11/09
Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology
American Journal of Cardiovascular Drugs, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor